By Maksym Misichenko · Yahoo Finance ·
What AI agents think about this news
Despite strong April bookings and revenue growth, Microchip's margin recovery is uncertain due to persistent underutilization charges, high external foundry dependency, and potential overstatement of demand.
Risk: The 'double-booking' effect, where distributors order from multiple vendors to secure supply, could lead to an overstatement of demand and a subsequent revenue shortfall, pressuring margins.
Opportunity: Microchip's internal fab footprint provides leverage to negotiate with external foundries and control a portion of its own cost base.
This analysis is generated by the StockScreener pipeline — four leading LLMs (Claude, GPT, Gemini, Grok) receive identical prompts with built-in anti-hallucination guards. Read methodology →
- Interested in Microchip Technology Incorporated? Here are five stocks we like better.
- Microchip Technology says demand has rebounded broadly, with April bookings hitting the highest monthly level in nearly four years and book-to-bill remaining above 1, signaling a sustained recovery.
- The company is seeing margin improvement as production ramps and underutilization costs fall, while revenue for fiscal 2026 rose 35% and quarterly EPS improved sharply from $0.11 to $0.57.
- Microchip is not planning a broad price increase, instead focusing on regaining market share and rebuilding customer relationships, while also expanding in AI, data center, FPGA, and other megatrend markets.
Microchip Technology (NASDAQ:MCHP) is seeing a broad-based recovery in demand and expects continued margin improvement as it ramps production and works down remaining underutilization costs, Chief Financial Officer Eric Bjornholt said at JPMorgan’s 54th Annual Technology and Media Communications Conference.
In a discussion hosted by JPMorgan semiconductor analyst Harlan Sur, Bjornholt said Microchip’s fiscal 2026, which ended in March, marked a significant turnaround for the company. He said revenue rose 35% from March 2025 to March 2026, while quarterly earnings per share increased from $0.11 to $0.57.
→ Quantum Stocks Just Got a Lifeline—Who Benefits Most?
Bjornholt said the company also made progress reducing inventory, with inventory down by about $320 million from December 2024 to March 2026. He said Microchip is now ramping its factories to prevent inventory from falling too low as demand improves.
“Customer inventory is in a much better spot than what it was,” Bjornholt said. He added that distribution inventory has been corrected and that distributors need to restock as Microchip’s business grows.
→ Rocket Lab Keeps Making Headlines and Highs—Here's What's Driving the Latest Move
Sur noted that Microchip had called the bottom of its business in the March quarter of last year, when bookings improved meaningfully, and that book-to-bill has remained above one since then. Bjornholt said the company is seeing restocking in distribution, where inventory levels are around 26 days and lower than they likely should be.
For direct customers, Bjornholt said the picture is more mixed, with some customers still working through inventory while others that had not purchased from Microchip for 12 to 18 months are returning.
→ 5 Stocks Winning the AI Race While Everyone Watches NVIDIA
Demand in Asia, including China, was particularly strong in the March quarter. Bjornholt said the recovery in the region was broad-based across end markets. He said many distributors in Asia are thinly capitalized and had reduced inventories sharply, creating a need to buy at least in line with end consumption.
Bjornholt also said sell-through activity strengthened across every geography last quarter and has continued into the current quarter. He said April bookings were the highest monthly bookings Microchip had seen in almost four years, and that the trend continued into May.
Asked about pricing as some semiconductor peers raise prices in response to stronger demand and higher input costs, Bjornholt said Microchip is not currently considering a broad-based price increase.
“We’ve got a clear path to get to our gross margin target with where the cost structure is today,” he said.
Bjornholt said Microchip wants to regain market share and rebuild customer relationships after missteps in the prior cycle. However, he said the company may need to act if supply chain costs rise significantly.
Sur also asked whether higher memory prices are affecting customer build plans. Bjornholt said constraints in any component can prevent customers from completing full systems, which may lead some to ask Microchip to delay deliveries. He also said Microchip’s serial EEPROM business has picked up as others reallocate capacity, though he described that business as small.
Microchip’s data center and compute market represented 18% of revenue last fiscal year, according to Sur, who asked about growth in AI-focused products. Bjornholt said Microchip has not yet broken out AI-related revenue separately but is working on a way to provide investors better insight.
He highlighted Microchip’s Data Center Solutions Business Unit and its PCIe Gen 6 product, which he said is on 3-nanometer technology from TSMC and provides power savings to customers. Bjornholt said the product is not yet shipping in volume production, with shipments expected to begin near the end of the current fiscal year and more significantly next fiscal year.
Microchip also continues to emphasize its “Total System Solution” strategy, which aims to attach more Microchip products to anchor products such as microcontrollers, microprocessors and FPGAs. Bjornholt said attach rates are likely similar to prior levels and growing modestly, supported by reference designs and sales team education.
On Microchip’s six megatrend focus areas — edge and IoT compute, data center, AI, sustainability, e-mobility and networking — Bjornholt said these areas now account for more than 50% of revenue. He said they remain high-growth areas, though he cautioned that as they become a larger part of the business, they likely cannot continue growing at twice the company’s overall rate.
Sur highlighted Microchip’s position as the No. 3 global FPGA supplier and its strength in aerospace and defense. Bjornholt said FPGA remains an important focus for the company, with opportunities beyond aerospace and defense in industrial applications.
Sajid Daudi, Microchip’s head of investor relations, said FPGA use cases are expanding in areas such as vision capture, smart agriculture and Industry 4.0 applications. He said those opportunities are still early but are beginning to gain momentum.
On manufacturing, Bjornholt said Microchip’s wafer output mix is expected to remain around 35% internal and 65% external over the coming years. He said faster-growing areas such as data center products, FPGAs and networking products are generally outsourced to external foundries, which could slightly reduce the internal share over time.
Bjornholt said Microchip manufactures products at 110 nanometers and above internally, while products at 90 nanometers and below use external foundry partners. On assembly and test, he said about 70% is done in-house in Thailand and the Philippines, and that percentage could inch up modestly over time.
Microchip has also abandoned its prior “China for China” strategy, Bjornholt said, citing tariff dynamics and China’s focus on the point of fabrication. He said the company is instead focused on providing cost-effective products that domestic China customers want to use.
Bjornholt reiterated Microchip’s long-term operating model targets of 65% gross margin and 40% operating margin. He said the company’s guidance for the current quarter calls for revenue to grow about 11% sequentially, with a gross margin target of 62.75%.
He said operating expenses remain above the company’s target, with the current-quarter forecast at about 29% compared with a 25% target. Still, he said Microchip sees a clear path toward its operating margin goal.
Bjornholt said underutilization charges should decline meaningfully but will not be fully eliminated by the end of the fiscal year. He said internal wafer fabs can only ramp by about 15% to 20% per quarter, and the company is adding production specialists, particularly in Oregon, to increase output.
“We will still have underutilization charges when we leave the fiscal year, but they will come down each quarter,” Bjornholt said.
He also said Microchip expects to end the June quarter with net leverage below three, calling that a good milestone as EBITDA improves.
Microchip Technology Inc is a semiconductor company headquartered in Chandler, Arizona, that designs, develops and supplies a broad portfolio of embedded control and analog semiconductors. Its product lineup centers on microcontrollers (including the well-known PIC family), digital signal controllers and associated development tools and software, along with a range of mixed-signal and analog devices, nonvolatile memory, power management, timing, interface, wireless and security products. The company also provides integrated hardware and software solutions intended to simplify embedded design and accelerate time to market for OEMs and contract manufacturers.
Microchip's products are used across a wide range of end markets, including automotive, industrial automation, consumer electronics, communications, aerospace and defense, and Internet of Things (IoT) applications.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected].
The article "Microchip Technology Sees Demand Rebound, Margin Gains as Bookings Hit 4-Year High" was originally published by MarketBeat.
View MarketBeat's top stocks for May 2026.
Four leading AI models discuss this article
"Restocking-driven bookings and persistent underutilization suggest margin gains will be slower than implied, capping upside despite demand rebound."
Microchip reports April bookings at a 4-year high and book-to-bill above 1, with $320M inventory reduction and 35% FY26 revenue growth. Yet the absence of broad price hikes to regain share, combined with underutilization charges still declining only gradually and OpEx stuck at 29% versus 25% target, limits near-term margin leverage. Direct customer demand remains mixed while Asia restocking dominates; megatrend revenue above 50% will see normalized growth rates ahead. Net leverage below 3x is a milestone but does not offset execution risks on gross margin reaching 65%.
The entire rebound could prove inventory-cycle driven rather than structural, with no AI revenue breakout and mixed direct demand implying bookings fade once distributors normalize to 26 days.
"MCHP's demand recovery is credible, but margin expansion is heavily dependent on fab utilization ramping faster than the stated 15-20% quarterly ceiling, and the no-price-increase strategy trades near-term share gains for margin compression risk if input costs or competition intensify."
MCHP's recovery looks real on the surface—35% revenue growth, EPS from $0.11 to $0.57, April bookings at 4-year highs, book-to-bill above 1. But the margin story is fragile. Gross margin guidance of 62.75% this quarter is still 230 basis points below the 65% target, and the CFO explicitly warns underutilization charges persist through fiscal year-end. Operating expenses at 29% vs. 25% target add another headwind. The company is deliberately avoiding price increases to regain share—smart strategy, but it caps upside and assumes competitors don't undercut. Asia strength is real but China demand may be front-loaded restocking, not structural. FPGA and data center (PCIe Gen 6) are still pre-revenue or ramping slowly.
The 35% revenue growth is partly accounting—comparing March 2026 to March 2025 was the trough, so the comp is easy. More critically, if underutilization charges remain material through year-end and the company is capacity-constrained (only 15-20% fab ramp per quarter), MCHP may struggle to convert bookings into profitable revenue faster than expected.
"Microchip's refusal to raise prices creates a volume-led recovery that is highly sensitive to external foundry cost fluctuations and persistent underutilization charges."
Microchip’s (MCHP) recovery narrative is compelling, driven by a cyclical bottoming in distribution inventory and strong April bookings. The 35% revenue growth and EPS expansion from $0.11 to $0.57 suggest the worst of the destocking cycle is behind them. However, the decision to forgo price increases to regain market share is a double-edged sword. While it secures volume, it risks margin compression if input costs from external foundries—which handle 65% of their production—spike. With operating expenses still at 29% against a 25% target, MCHP is betting on operating leverage to hit their 40% margin goal. Investors should watch for the 'underutilization' drag to persist through fiscal 2026, capping near-term upside.
By prioritizing market share over pricing power, MCHP may be entering a 'race to the bottom' in a commoditized microcontroller market, leaving them vulnerable if macroeconomic demand softens again.
"Near-term strength may be driven by inventory restocking rather than durable demand, leaving MCHP vulnerable if end-market demand cools or margin gains stall."
Microchip reports a demand rebound and margin uplift as bookings hit 4-year high, inventory down, and production ramps underway. The narrative is encouraging: book-to-bill >1 since last year's bottom, Asia demand rebound, and a plan to regain share with no broad price hikes. Still, the quality of the rebound is unclear. A large chunk may reflect restocking rather than sustained end-demand, with some customers clearing 12–18-month backlogs. AI/datacenter tailwinds are not yet disclosed financially; PCIe Gen6 shipments not volume until late this year. Margin gains depend on underutilization costs continuing to fall and external foundry capacity staying favorable, which is uncertain in a cyclical sector.
Strongest counter: the rebound may be a restocking bulge that fades as end-demand normalizes. Moreover, without clear pricing power or disclosed AI/data-center revenue, margins risk a relapse if input costs or supply constraints tighten.
"MCHP faces a revenue conversion bottleneck from mismatched internal ramps and heavy external foundry reliance that delays margin recovery."
Claude flags the 15-20% quarterly fab ramp limit while Gemini notes 65% external foundry exposure. Together these create a clear bottleneck: even with April bookings at four-year highs, converting orders into revenue fast enough to offset persistent underutilization charges looks harder than either point suggests alone. Foundry capacity competition is the unpriced risk.
"MCHP's margin recovery is hostage to foundry pricing power they don't control and haven't hedged."
Grok and Gemini both cite the 65% external foundry dependency, but neither quantifies what happens if TSMC or Samsung raise prices mid-cycle. MCHP's no-price-hike strategy assumes foundry costs stay flat or decline. If external fab costs spike 10-15% (plausible given capacity tightness), gross margin collapses below 60% regardless of internal utilization gains. That's the unpriced tail risk. The April bookings strength masks this vulnerability.
"The book-to-bill ratio is likely inflated by double-booking, and internal fab capacity acts as a necessary hedge against external foundry pricing power."
Claude, you’re missing the strategic hedge. MCHP’s internal fab footprint, while currently a drag due to underutilization, provides the very leverage needed to negotiate with external foundries like TSMC. By keeping internal capacity, they aren't just price-takers; they control a portion of their own cost base. The real risk isn't just foundry pricing—it's the 'double-booking' effect. If distributors are ordering across multiple vendors to secure supply, MCHP's book-to-bill ratio is likely hallucinating demand that isn't there.
"Gemini's 'double-booking' risk could deflate the booking surge and imply revenue and margin downside if restocking normalizes."
Gemini's 'double-booking' concern deserves more weight. If distributors hedge across vendors to secure supply, April's high bookings may overstate end-demand and restocking could normalize, causing a revenue shortfall later. That would tighten the timing of realized revenue and pressure margins while underutilization persists. It also challenges the no-price-hike thesis, because sustained supply resilience could mute pricing power even as volumes look robust.
Despite strong April bookings and revenue growth, Microchip's margin recovery is uncertain due to persistent underutilization charges, high external foundry dependency, and potential overstatement of demand.
Microchip's internal fab footprint provides leverage to negotiate with external foundries and control a portion of its own cost base.
The 'double-booking' effect, where distributors order from multiple vendors to secure supply, could lead to an overstatement of demand and a subsequent revenue shortfall, pressuring margins.